Prevention and diminished expression of experimental autoimmune encephalomyelitis by low dose naltrexone (LDN) or opioid growth factor (OGF) for an extended period: Therapeutic implications for multiple sclerosis.
Rahn KA, McLaughlin PJ, Zagon IS
Brain Res. 2011 Mar 24; 1381:243-53. Epub 2011 Jan 20. PMID: 21256121.Abstract